BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 33149230)

  • 1. Characterization of somatic mutation-associated microenvironment signatures in acute myeloid leukemia patients based on TCGA analysis.
    Wang J; Dao FT; Yang L; Qin YZ
    Sci Rep; 2020 Nov; 10(1):19037. PubMed ID: 33149230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia.
    Dao FT; Wang J; Yang L; Qin YZ
    Sci Rep; 2021 Mar; 11(1):4856. PubMed ID: 33649342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic genes in the acute myeloid leukemia microenvironment.
    Huang S; Zhang B; Fan W; Zhao Q; Yang L; Xin W; Fu D
    Aging (Albany NY); 2019 Nov; 11(22):10557-10580. PubMed ID: 31740623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
    Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
    J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics Analysis to Determine Prognostic Mutations of 72 de novo Acute Myeloid Leukemia Cases from the Cancer Genome Atlas (TCGA) with 23 Most Common Mutations and no Abnormal Cytogenetics.
    Welsh KJ; Nedelcu E; Wahed A; Bai Y; Dasgupta A; Nguyen A
    Ann Clin Lab Sci; 2015; 45(5):515-21. PubMed ID: 26586702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
    Lai Y; Sheng L; Wang J; Zhou M; OuYang G
    Technol Cancer Res Treat; 2021; 20():15330338211004933. PubMed ID: 33784904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.
    Lin PH; Li HY; Fan SC; Yuan TH; Chen M; Hsu YH; Yang YH; Li LY; Yeh SP; Bai LY; Liao YM; Lin CY; Hsieh CY; Lin CC; Lin CH; Lien MY; Chen TT; Ni YH; Chiu CF
    Cancer Med; 2017 Feb; 6(2):349-360. PubMed ID: 28070990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
    Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
    Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
    Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
    Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
    Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
    Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis.
    Yan H; Qu J; Cao W; Liu Y; Zheng G; Zhang E; Cai Z
    Cancer Immunol Immunother; 2019 Dec; 68(12):1971-1978. PubMed ID: 31650199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
    Li C; Liu T; Liu Y; Zhang J; Zuo D
    J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Analyses of
    Wen XM; Xu ZJ; Jin Y; Xia PH; Ma JC; Qian W; Lin J; Qian J
    Front Immunol; 2021; 12():717527. PubMed ID: 34745095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia.
    Jiang F; Mao Y; Lu B; Zhou G; Wang J
    Sci Rep; 2021 Jul; 11(1):14657. PubMed ID: 34282207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.
    Zhao X; Tang Y; Ren H; Lei Y
    Biomed Res Int; 2020; 2020():9143695. PubMed ID: 33204728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutations.
    Rollins-Raval M; Pillai R; Warita K; Mitsuhashi-Warita T; Mehta R; Boyiadzis M; Djokic M; Kant JA; Roth CG
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):212-7. PubMed ID: 22914610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
    Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
    Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.